DuPont Nutrition and Health has teamed up with Inbiose to develop breast milk polysaccharies

DuPont and
Inbiose
, a Belgian special carbohydrate producer, announced a joint development and licensing agreement for certain algal-based breast milk
(HMOs
such as
2
'
-
algae-based lactose. Breast milk lysate
(HMOs)
is a unique class of lysate found in breast milk, of which
2
'
-
algal-based lactose content is highest."s partnership is part of a new era of ingredients for infant nutrition," said
John Rea
, global business leader for probiotics, fermented strains, food preservation and breast milk polysaccharides in DuPont's Nutrition and Health division. "With this development, we are working to achieve our corporate goals to help address the global food challenge by providing our customers with innovative ingredients for the manufacture of healthy nutritional products. Our investment complements DuPont's existing capabilities in probiotics and the human gut microbiome, as well as technologies that have been targeted in this area.milk lysose
(HMOs) is a unique class of lysosaccharies found in breast milk, with the highest levels of
2'
-
algal-based lactose. This new partnership combines
Inbiose
's special carbohydrate innovation production platform with DuPont's industrial-scale fermentation, regulation, health technology expertise, and global market coverage.cooperation is currently focused on developing ingredients for use in2017 through the implementation of industrial-scale fermentation processes and the submission of regulatory approvals. "We are pleased to be working with
Inbiose
to bring the technology of breast milk polysaccharides to market," said
Martin Kullen
, Global Head of Research and Development for Probiotics, Fermented Bacteria, Food Preservation and Breast Milk Lycosaccharides. "Breast milk lysose is key to helping our customers' infant nutrition products get closer to the milk content."milk LYUC
(HMOs
has been identified as an important ingredient in human breast milk, helping to adjust the baby's gut microbiome and balance the immune system. There is growing evidence that breast milk polysaccharose supports digestion, immunity and cognitive system development
1
, which is beneficial to infant growth and health.We work with DuPont, the world's leading food ingredients manufacturer, to advance our technology and accelerate the introduction of our first breast milk lysose

(HMO)
product to improve the health and well-being of infants," said professor
WimSoetaert
, executive chairman of
Inbiose
.digestion of
/
's gut health is the primary claim of infant formula that went on the market in

, according to market research firm
Innova2
. 58% of
new products
adopted this claim. In the past five years, the use of probiotics in infant formula has increased dramatically."Breast Milk Lycosaccharies
( HMOs)
naturally present in breast milk and represents the next generation of functional LYOs. Adding breast milk LYP
(HMOs)
can make significant progress in improving infant formula,"
Kullen
said. "With our experience in providing strict safety and efficacy standards for infant formula products, DuPont will be at the forefront of commercial breast milk low polysaccharide
(HMOs
About
InbioseInbiose
is a Belgian company that develops proprietary production platforms for the industrial production of special carbohydrates. Breast milk polysaccharina
(HMOs)
is an important target for
Inbiose
, and the launch of
2
'
-
algal-based lactose on the market is an important milestone for the company.
Inbiose
is developing new processes for other breast milk polysaccharin
(HMOs
and special carbohydrates.About DuPontDuPont Nutrition and Health provides a range of sustainable, biotechnology-based ingredients and advanced microbiological testing solutions to deliver safer, healthier and more nutritious foods to meet global food challenges. By working closely with our customers, DuPont translates knowledge and experience into a passion for research and development that gives the market unparalleled customer value.